Month: June 2020

Reviewed by Emily Henderson, B.Sc.Jun 5 2020 In nationwide demonstrations sparked by the killing of George Floyd in police custody, protesters have been frequently pepper-sprayed or enveloped in clouds of tear gas. These crowd-control weapons are rarely lethal, but in the middle of the coronavirus pandemic, there are strong calls for police to stop using
0 Comments
As the global death toll of Covid-19 surpasses 390,000, the spread of the virus continues to accelerate in parts of Latin America and Eastern Europe, according to the World Health Organization. Daily new confirmed cases are pushing new highs, according to data compiled by Johns Hopkins University, with an all-time high of 130,400 new cases
0 Comments
There’s nothing like a good night’s sleep. But for people with obstructive sleep apnea, decent shut eye is hard to get. They often snore and repeatedly stop breathing during the night. This not only causes daytime sleepiness, but also other health issues. More on risks of sleep apnea and what you can do about it
0 Comments
Coronavirus hospitalizations are on the rise around the country, Dr. Scott Gottlieb told CNBC Thursday, as states push forward with plans to reopen the economy and mass protests engulf the country. That could become a problem in the fall, when hospitals around the country begin to fill with flu patients. As the two outbreaks coincide,
0 Comments
Head injuries that lead to concussions can happen at any age, and children impacted by concussions have different needs and recovery patterns. In a new study, researchers at Children’s Hospital of Philadelphia (CHOP) have performed the most comprehensive characterization of elementary school-age concussions to date, revealing an opportunity to improve outcomes for this age group
0 Comments
Reviewed by Emily Henderson, B.Sc.Jun 3 2020 Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients. Unlike what a biology textbook may show, blood vessels are not straight cylinders. They are tortuous, meaning they have complex curves, spirals
0 Comments
Executive Director of the World Health Organization’s (WHO) emergencies program Mike Ryan speaks at a news conference on the novel coronavirus (2019-nCoV) in Geneva, Switzerland February 6, 2020. Denis Balibouse | Reuters The coronavirus has not mutated in any way that would meaningfully change how quickly it spreads or how severely it can harm humans,
0 Comments
School-based mindfulness programs can improve decision-making skills and teach children with autism to focus attention and react less impulsively through breathing exercises that will allow them to reduce anxiety, according to Rutgers researchers. The study, published in the journal Research in Developmental Disabilities, is the first to examine the effectiveness of a school-based mindfulness program
0 Comments
Dr. Vishal Khullar joined the department of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota in 2018. He completed his residency training in cardiovascular and thoracic surgery from Bombay Hospital and Medical Research Center, Mumbai, India. He continued his training in advanced cardiovascular surgery at Mayo Clinic in Rochester, MN, and sub-specialization training in advanced
0 Comments
A research group from Germany demonstrated a direct toxic effect of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on cardiac cells in their paper published on the bioRxiv* preprint server. The finding warrants an in-depth analysis of cardiac tissue in certain coronavirus disease (COVID-19) patients, as well as close monitoring for any direct cardiomyocyte
0 Comments
In the U.S., our children rarely fall ill to grave infections because they are protected by vaccines. Serious illnesses like measles, mumps, congenital rubella syndrome, chickenpox, diphtheria, tetanus, whooping cough, rotavirus diarrhea, hepatitis (A and B), polio and bacterial meningitis are all preventable through routine childhood vaccinations. It is not magic that keeps our children
0 Comments
Drug company Biogen Inc. intends to pursue regulatory approval from the Food and Drug Administration (FDA) for their experimental Alzheimer’s drug, aducanumab, based on new analyses of data from their Phase 3 clinical trials. The study results showed reduced decline in people with mild cognitive impairment and mild dementia due to Alzheimer’s disease who received
0 Comments
Reviewed by Emily Henderson, B.Sc.Jun 1 2020 A paper recently published online in the journal Chest reports on a study of the palliative ventilator withdrawal (PVW) procedure performed in intensive care units (ICU) at end of life. The study’s goal was to determine the level of distress patients experience and identify treatments that could bring
0 Comments
earn free cme credit Earn CME credit by reading this article and completing the posttest. Sign Up Study Authors: Peter K. Lindenauer, Mihaela S. Stefan, et al.; Carolyn L. Rochester, Anne E. Holland Target Audience and Goal Statement: Pulmonologists, hospitalists The goal of this study was to determine the association between initiation of pulmonary rehabilitation
0 Comments
People across the U.S. gathered in mass over the weekend and into Monday morning to protest police brutality and the killing of George Floyd in Minneapolis, raising concerns of further virus spread through the demonstrations. More than 1.7 million people in the U.S. have tested positive for the virus and more than 104,000 have died
0 Comments
When people with celiac disease or non-celiac gluten sensitivity continue to have symptoms, they may be interested in exploring new diets. Jacalyn See, clinical dietitian at Mayo Clinic, offers some insight into the FODMAP diet, and whether this diet could help people with gluten-related disorders. To learn more, visit https://mayocl.in/2Nz8cIz
0 Comments
An anti-inflammatory drug Ruxolitinib has shown promising results in the treatment of severe coronavirus disease COVID-19. The study titled, “Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial,” was published as a pre-proof for the Journal of Allergy and Clinical Immunology. What is Ruxolitinib? The researchers explain, Ruxolitinib is
0 Comments